- Home
- FMC vs ALKS Comparison
FMC vs ALKS Comparison
Compare FMC & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMC
- ALKS
- Stock Information
- Founded
- FMC 1910
- ALKS 1987
- Country
- FMC United States
- ALKS Ireland
- Employees
- FMC N/A
- ALKS N/A
- Industry
- FMC Major Chemicals
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- FMC Industrials
- ALKS Health Care
- Exchange
- FMC Nasdaq
- ALKS Nasdaq
- Market Cap
- FMC 4.8B
- ALKS 4.8B
- IPO Year
- FMC N/A
- ALKS 1991
- Fundamental
- Price
- FMC $40.57
- ALKS $30.84
- Analyst Decision
- FMC Hold
- ALKS Buy
- Analyst Count
- FMC 13
- ALKS 13
- Target Price
- FMC $50.38
- ALKS $38.85
- AVG Volume (30 Days)
- FMC 2.0M
- ALKS 1.6M
- Earning Date
- FMC 07-30-2025
- ALKS 07-23-2025
- Dividend Yield
- FMC 5.72%
- ALKS N/A
- EPS Growth
- FMC N/A
- ALKS N/A
- EPS
- FMC 2.62
- ALKS 2.09
- Revenue
- FMC $4,119,500,000.00
- ALKS $1,513,770,000.00
- Revenue This Year
- FMC N/A
- ALKS N/A
- Revenue Next Year
- FMC $6.08
- ALKS $4.11
- P/E Ratio
- FMC $13.23
- ALKS $14.52
- Revenue Growth
- FMC 1.45
- ALKS N/A
- 52 Week Low
- FMC $32.83
- ALKS $22.90
- 52 Week High
- FMC $68.55
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- FMC 57.64
- ALKS 47.14
- Support Level
- FMC $37.46
- ALKS $29.20
- Resistance Level
- FMC $40.99
- ALKS $30.57
- Average True Range (ATR)
- FMC 1.17
- ALKS 0.70
- MACD
- FMC 0.22
- ALKS -0.10
- Stochastic Oscillator
- FMC 90.16
- ALKS 27.54
About FMC FMC Corporation
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.